Report of the Global Advisory Committee on Vaccine Safety; 2012

Overview

The Global Advisory Committee on Vaccine Safety (GACVS), an expert clinical and scientific advisory body, was established by WHO to provide independent, scientifically rigorous advice on vaccine safety issues of potential global importance. GACVS held its 27th meeting in Geneva, Switzerland, on 5–6 December 2012. The committee reviewed: the safety profile of varicella vaccines; the risk of narcolepsy related to use of Pandemrix® and that of Guillain-Barré syndrome (GBS) with multiple influenza A (H1N1) pdm09 vaccine use; and safety aspects of development of dengue vaccines. GACVS also reviewed progress with implementation of the Global Vaccine Safety Blueprint through the Global Vaccine Safety Initiative.